G0600773/MRC_/Medical Research Council/United Kingdom[Grant Number] - Search Results

Year	Number of Results
2009	1
2012	4
2013	2
2014	1
2015	1
2016	1
2017	3
2018	1
2019	1
2022	0

1

Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.

Kohn DB, Hershfield MS, Puck JM, Aiuti A, Blincoe A, Gaspar HB, Notarangelo LD, Grunebaum E. Kohn DB, et al. J Allergy Clin Immunol. 2019 Mar;143(3):852-863. doi: 10.1016/j.jaci.2018.08.024. Epub 2018 Sep 5. J Allergy Clin Immunol. 2019. PMID: 30194989 Free PMC article. Review.

2

Gene Therapy Approaches to Immunodeficiency.

Ghosh S, Gaspar HB. Ghosh S, et al. Hematol Oncol Clin North Am. 2017 Oct;31(5):823-834. doi: 10.1016/j.hoc.2017.05.003. Epub 2017 Jun 29. Hematol Oncol Clin North Am. 2017. PMID: 28895850 Free article. Review.

3

Gene therapy for primary immunodeficiencies.

Rivat C, Santilli G, Gaspar HB, Thrasher AJ. Rivat C, et al. Hum Gene Ther. 2012 Jul;23(7):668-75. doi: 10.1089/hum.2012.116. Hum Gene Ther. 2012. PMID: 22691036 Free PMC article. Review.

4

Adenosine Deaminase Deficiency - More Than Just an Immunodeficiency.

Whitmore KV, Gaspar HB. Whitmore KV, et al. Front Immunol. 2016 Aug 16;7:314. doi: 10.3389/fimmu.2016.00314. eCollection 2016. Front Immunol. 2016. PMID: 27579027 Free PMC article. Review.

5

Current progress on gene therapy for primary immunodeficiencies.

Zhang L, Thrasher AJ, Gaspar HB. Zhang L, et al. Gene Ther. 2013 Oct;20(10):963-9. doi: 10.1038/gt.2013.21. Epub 2013 May 30. Gene Ther. 2013. PMID: 23719067 Review.

6

Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency.

Montiel-Equihua CA, Thrasher AJ, Gaspar HB. Montiel-Equihua CA, et al. Curr Gene Ther. 2012 Feb 1;12(1):57-65. doi: 10.2174/156652312799789253. Curr Gene Ther. 2012. PMID: 22348551 Review.

7

How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID).

Kohn DB, Gaspar HB. Kohn DB, et al. J Clin Immunol. 2017 May;37(4):351-356. doi: 10.1007/s10875-017-0373-y. Epub 2017 Feb 14. J Clin Immunol. 2017. PMID: 28194615 Review.

8

Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency.

Montiel-Equihua CA, Thrasher AJ, Gaspar HB. Montiel-Equihua CA, et al. Stem Cells Cloning. 2009 Dec 22;3:1-12. doi: 10.2147/sccaa.s5570. Stem Cells Cloning. 2009. PMID: 24198507 Free PMC article. Review.

9

Gene therapy for monogenic disorders of the bone marrow.

Ghosh S, Thrasher AJ, Gaspar HB. Ghosh S, et al. Br J Haematol. 2015 Oct;171(2):155-170. doi: 10.1111/bjh.13520. Epub 2015 Jun 5. Br J Haematol. 2015. PMID: 26044877 Review.

10

Gene therapy for ADA-SCID: defining the factors for successful outcome.

Gaspar HB. Gaspar HB. Blood. 2012 Nov 1;120(18):3628-9. doi: 10.1182/blood-2012-08-446559. Blood. 2012. PMID: 23118212 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results